The microbiological hydroxylation of levonorgestrel

Natural Product Research

Volumn 20, Issue 12, 2006, Pages 1074-1081

  Choudhary, Muhammad Iqbal ^a   Sarfraz, Muhammad Atif ^a   Nawaz, A ^a   Fatmi, Muhammad Qaiser ^a   Atta ur Rahman, ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase; Cunninghamella elegans; Enzyme inhibition; Levonorgestrel (13 ethyl 17 hydroxy 18,19 dinor 17 pregn 4 en 20 yn 3 one); Microbial transformation

Indexed keywords

13 ETHYL 10BETA,17BETA DIHYDROXY 18,19 DINOR 17ALPHA PREGN 4 EN 20 YN 3 ONE; 13 ETHYL 11ALPHA,17BETA DIHYDROXY 18,19 DINOR 17ALPHA PREGN 4 EN 20 YN 3 ONE; 13 ETHYL 15ALPHA,17BETA DIHYDROXY 18,19 DINOR 17ALPHA PREGN 4 EN 20 YN 3 ONE; 13 ETHYL 6BETA,10BETA,17BETA TRIHYDROXY 18,19 DINOR 17ALPHA PREGN 4 EN 20 YN 3 ONE; 13 ETHYL 6BETA,17BETA DIHYDROXY 18,19 DINOR 17ALPHA PREGN 4 EN 20 YN 3 ONE; ACETYLCHOLINESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DRUG METABOLITE; GALANTAMINE; LEVONORGESTREL; UNCLASSIFIED DRUG; 13-ETHYL-10BETA,17BETA-DIHYDROXY-18,19-DINOR-17ALPHA-PREGN-4-EN-20-YN-3-ONE; PREGNANE DERIVATIVE;

ARTICLE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; CUNNINGHAMELLA; CURVULARIA LUNATA; DRUG DECOMPOSITION; DRUG HYDROXYLATION; DRUG STRUCTURE; DRUG TRANSFORMATION; FUSARIUM; IC 50; NONHUMAN; RHIZOPUS; SPECTROSCOPY; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; FERMENTATION; HYDROXYLATION; MASS SPECTROMETRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

COCHLIOBOLUS LUNATUS; CUNNINGHAMELLA ELEGANS; FUSARIUM OXYSPORUM F. SP. LINI;

BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; CUNNINGHAMELLA; FERMENTATION; HYDROXYLATION; INHIBITORY CONCENTRATION 50; LEVONORGESTREL; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; NORPREGNANES; SPECTRUM ANALYSIS;

EID: 33947589493     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410500463411     Document Type: Article

References (15)

1. Hardman, JG and Limbird, LE and Gilman, AG.(2001) The Pharmacological Basis of Therapeutics. New York: Medicinal Publishing Division, McGraw-Hill.
2. Glasier, A. (2000) Br. Med. Bull., 56, pp. 729.
3. Choudhary, MI and Sultan, S and Yaqoob, M and Musharraf, SG and Yassin, A and Shaheen, F. (2003) Nat. Prod. Res., 17, pp. 389.
4. Choudhary, MI and Musharraf, SG and Shaheen, F and Atta-ur-Rahman. (2002) Nat. Prod. Lett., 16, pp. 377.
5. Choudhary, MI and Shah, SAA and Musharraf, SG and Shaheen, F and Atta-ur-Rahman. (2003) Nat. Prod. Res., 17, pp. 215.
6. Choudhary, MI and Musharraf, SG and Khan, MTH and Abdelrahman, D and Parvaz, M and Shaheen, F and Atta-ur-Rahman. (2003) Helv. Chim. Acta, 86, pp. 3450.
7. Choudhary, MI and Musharraf, SG and Ali, RA and Atif, M and Atta-ur-Rahman. (2004) Z. Naturforsch., 59b, pp. 323.
8. Hu, S-H and Tian, X-F and Sun, Y-H and Han, G-H. (1996) Steroids, 61, pp. 407.
9. Hu, S-H and Tian, X-F and Han, G-D. (1998) Steroids, 63, pp. 88.
10. Tougu, V. (2001) Curr. Med. Chem., 1, pp. 155.
11. Perry, EK. (1986) Br. Med. Bull., 42, pp. 63.
12. Ellman, GL and Courtney, KD and Andres, V and Featherstone, RM. (1961) Biochem. Pharmacol., 7, pp. 88.
13. Choudhary, MI and Devkota, KP and Nawaz, SA and Shaheen, F and Atta-ur-Rahman. (2004) Helv. Chem. Acta, 87, pp. 1099.
14. Cleve, G and Frost, E and Hoyer, GA and Rosenberg, D and Seeger, A. (1986) Arzneim-Forsch., 36, pp. 784.
15. Hammann, PE and Wobbecke, E and Hoppen, OH. (1990) Magn. Reson. Chem., 28, pp. 656.